干细胞治疗促进肩袖再生:前瞻性单中心随机对照试验研究方案(Lipo-cuff)
本研究为前瞻性优效性平行组单中心随机对照试验,在丹麦纳入30名40至69岁肩袖撕裂患者,按1:1随机分配至肩胛下肌腱重建联合微碎片脂肪组织注射(干细胞治疗)组或常规手术标准治疗组。主要结局为术后12个月牛津肩关节评分。
要点
- 纳入30名40至69岁肩袖撕裂患者,1:1随机分至微碎片脂肪组织注射联合手术组或常规手术组。
- 主要结局为术后12个月牛津肩关节评分。
- 患者、项目助理、医生和结局评估者因实际限制未设盲,放射科医生和统计师设盲。
核心结论
- 本研究将评估在常规肩袖撕裂治疗中加入微碎片脂肪组织治疗是否能促进恢复、加速重返日常活动并改善功能结局。
- 研究还将确定这一微创操作能否标准化用于常规患者照护。
研究设计与样本
- 前瞻性优效性平行组单中心随机对照试验,在丹麦纳入30名40至69岁患者,按1:1比例随机分配。
主要发现
- 原文未报告结果。
关键数值与推荐
- 主要结局为术后12个月牛津肩关节评分。
- 干预组为肩胛下肌腱重建联合向相关肌肉注射微碎片脂肪组织(干细胞治疗),对照组为常规手术标准治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 患者、项目助理、医生和结局评估者因实际限制未对随机分组设盲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rotator cuff tears (RCT) are a common musculoskeletal condition, especially in the aging population. The prevalence of rotator cuff tears varies based on factors like age, occupation, and activity level. In the general population, the prevalence of rotator cuff tears is estimated to be around 20 to 25%. Rotator cuff tears (RCT) have an impact in patients' pain level, shoulder function, sleep disturbance, and quality of life. Primary tendon surgery is in mostly cases necessary. This study aimed to examine if treatment of rotator cuff lesions with implantation of micro-fragmented adipose tissue can improve patients' reported pain and function compared to conventional surgery. METHODS: The study is a prospective superiority parallel-group single-center randomized controlled trial including 30 patients between 40 and 69 years of age in Denmark. Patients will be allocated 1:1 ratio to reconstruction of the supraspinatus tendon with an injection of micro-fragmented adipose tissue into the related muscle (stem cell treatment) or the standard of care (SOC), which is conventional surgery. Patients, project assistants, physicians, and outcome adjudicators are not blinded to randomization due to practical constraints. The radiologist and the statistician performing the analysis will be blinded. The primary outcome will be the Oxford shoulder score at 12 months post-surgery. DISCUSSION: This study will assess whether adding micro-fragmented adipose tissue therapy to conventional rotator cuff tear treatment can enhance recovery, accelerate return to daily activities, and improve functional outcomes. The research will also determine if this minimally invasive procedure could be standardized for routine patient care. TRIAL REGISTRATION: ClinicalTrials.gov NCT06505135. Registered on July 10, 2024.
引用
- Cartuliares MB, Hejbøl EK, Schrøder HD, et al. Stem cell treatment for regeneration of the rotator cuff: study protocol for a prospective single-center randomized controlled trial (Lipo-cuff). Trials. 2024. PMID: 39427182. doi:10.1186/s13063-024-08557-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。